Menu

Radiopharm Theranostics Limited RADX

Full chart Compare
Set alert

Price alert · RADX

All alert types
0.96 USD +0.07 (+7.85%)

At closeNov 6, 2026, 4:00 PM EST

0.94 -0.02 -2.43%

After hours · Nov 6, 4:00 PM ET

0.92 Day range 1.08
0.869 52-week range 10.63
YTD
-81.63%
1 year
-78.83%

Revenue & Expenses

Other Income → Expenses: $12.84MExpenses → Gross Loss: $2.10MExpenses → Selling, General & Admin: $15.86MExpenses → Other Operating Expenses: $48.87MIncome Tax Benefit → Expenses: $53.25KNet Loss → Expenses: $53.94MRevenue → Cost of Revenue: $2.71MOther Income$12.84MIncome Tax Benefit$53.25KNet Loss$53.94MCost of Revenue$4.81MExpenses$66.84MGross Loss$2.10MSelling, General & Admin$15.86MOther Operating Expenses$48.87MRevenue$2.71M

Latest period ending Jun 30, 2026 · select a line to chart its full history

Annual income statement

RADX annual income statement
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022
2.77M3.63M299.23K292.36K0
1.91M2.39M199.49K193.53K0
2.50M3.59M000
263.39K39.28K299.23K292.36K0
67.78M48.47M48.85M40.84M21.03M
49.96M27.52M23.09M22.63M7.49M
16.22M14.64M13.04M12.23M7.64M
-67.52M-48.43M-48.55M-40.55M-21.03M
112.40K65.30K642.89K86.09K9.35M
54.44K103.29K96.36K38.01K44.40K
-54.53M-36.24M-45.78M-35.18M-30.40M
-54.53M-36.24M-45.78M-35.18M-30.40M
-37.70M-23.84M-30.52M-23.29M-20.97M
-56.95M-38.34M-47.95M-34.61M-30.42M
-2.42M-2.10M-2.17M565.72K-19.04K
-5.37-5.28-37.23-33.96-50.34
-3.71-3.47-24.82-22.48-34.72
-5.37-5.28-37.23-33.96-50.34
-54.36M-36.07M-45.04M-35.05M-21.01M
-37.58M-23.73M-30.03M-23.20M-14.49M
2.36B2.20B338.95M338.95M255.43M